H. Suh

发表

Apoptosis and modulation of cell cycle control by synthetic derivatives of ursodeoxycholic acid and chenodeoxycholic acid in human prostate cancer cells.

Y. Yoo, Yung-Hyun Choi, E. Im, 2003, Cancer letters.

Novel bile acid derivatives induce apoptosis via a p53-independent pathway in human breast carcinoma cells.

Y. Yoo, E. Im, N. D. Kim, 2001, Cancer letters.

Synthetic bile acid derivatives induce nonapoptotic death of human retinal pigment epithelial cells

Y. Yoo, Yung-Hyun Choi, N. D. Kim, 2001, Current eye research.

Resveratrol analogue HS-1793 induces the modulation of tumor-derived T cells.

Sung Dae Kim, Y. Yoo, H. Suh, 2012, Experimental and therapeutic medicine.

The novel resveratrol analogue HS-1793 induces apoptosis via the mitochondrial pathway in murine breast cancer cells

H. Suh, M. Jeong, Kwangmo Yang, 2012, International journal of oncology.

Resveratrol analog, HS-1793 enhance anti-tumor immunity by reducing the CD4+CD25+ regulatory T cells in FM3A tumor bearing mice.

Sung Dae Kim, Y. Yoo, H. Suh, 2012, International immunopharmacology.

Differential effects of resveratrol and novel resveratrol derivative, HS-1793, on endoplasmic reticulum stress-mediated apoptosis and Akt inactivation.

Y. Yoo, H. J. Um, T. Kwon, 2010, International journal of oncology.

Synthetic bile acid derivatives induce apoptosis through a c-Jun N-terminal kinase and NF-kappaB-dependent process in human cervical carcinoma cells.

Y. Yoo, Yung-Hyun Choi, E. Im, 2005, Cancer letters.

A chenodeoxycholic derivative, HS-1200, induces apoptosis and cell cycle modulation via Egr-1 gene expression control on human hepatoma cells.

Min Young Kim, Yung-Hyun Choi, Y. Park, 2008, Cancer letters.

Synthetic chenodeoxycholic acid derivatives inhibit glioblastoma multiform tumor growth in vitro and in vivo.

Y. Yoo, Ji Young Kim, N. Kim, 2005, International journal of oncology.

Induction of apoptosis in HepG2 human hepatocellular carcinoma cells by a novel derivative of ursodeoxycholic acid (UDCA)

T. Kim, H. Suh, J. Baek, 1997, Archives of pharmacal research.

Inhibition of initiation of simian virus 40 DNA replication in vitro by the ursodeoxycholic acid and its derivatives.

N. D. Kim, K. W. Kim, H. Suh, 1999, Cancer letters.

Apoptotic activity of novel bile acid derivatives in human leukemic T cells through the activation of caspases.

W. Lee, Y. Yoo, E. Im, 2001, International journal of oncology.

A novel chenodeoxycholic derivative HS-1200 enhances radiation-induced apoptosis in MCF-7 cells.

Y. Yoo, N. Kim, H. Suh, 2007, Oncology reports.

Orphan Nuclear Receptor Nur77 Translocates to Mitochondria in the Early Phase of Apoptosis Induced by Synthetic Chenodeoxycholic Acid Derivatives in Human Stomach Cancer Cell Line SNU‐1

Y. Yoo, N. Kim, H. Suh, 2003, Annals of the New York Academy of Sciences.

Antiinflammatory Effects of New Chemical Compounds, HS-1580 Series(HS-1580, HS-1581, HS-1582)

Ji-Young Kim, H. Suh, K. Kim, 2006 .

Adenocarcinoma with Yolk Sac Tumor of the Stomach : Case Report with Review of the Literature and an Immunohistochemical Study

H. Suh, Mi Ja Lee, Ran Hong∙Chae, 2007 .

A novel resveratrol analogue HS-1793 treatment overcomes the resistance conferred by Bcl-2 and is associated with the formation of mature PML nuclear bodies in renal clear cell carcinoma Caki-1 cells.

Y. Yoo, T. Kwon, H. Suh, 2009, International journal of oncology.

A novel resveratrol derivative, HS1793, overcomes the resistance conferred by Bcl-2 in human leukemic U937 cells.

Y. Yoo, S. Leem, T. Kwon, 2009, Biochemical pharmacology.

Efficacy on anaplastic thyroid carcinoma of valproic acid alone or in combination with doxorubicin, a synthetic chenodeoxycholic acid derivative, or lactacystin.

Y. Yoo, H. Suh, Ki-Jae Park, 2009, International journal of oncology.

Synthetic bile acid derivatives inhibit cell proliferation and induce apoptosis in HT-29 human colon cancer cells.

Y. Yoo, H. Chung, Yung-Hyun Choi, 2004, International journal of oncology.

HS-1793, a resveratrol analogue, induces cell cycle arrest and apoptotic cell death in human breast cancer cells.

Min Young Kim, H. Chung, N. Kim, 2014, International journal of oncology.

The novel resveratrol analog HS-1793-induced polyploid LNCaP prostate cancer cells are vulnerable to downregulation of Bcl-xL.

Y. Yoo, Yung-Hyun Choi, H. Suh, 2011, International journal of oncology.

Synthetic chenodeoxycholic acid derivative HS-1200-induced apoptosis of p815 mastocytoma cells is augmented by co-treatment with lactacystin

Y. Yoo, N. Kim, H. Suh, 2003, Anti-cancer drugs.

A Novel Ursodeoxycholic Acid Derivative Induces Apoptosis in Human MCF-7 Breast Cancer Cells

E. Im, N. Kim, H. Suh, 1999 .

HS-1793, a resveratrol analogue, downregulates the expression of hypoxia-induced HIF-1 and VEGF and inhibits tumor growth of human breast cancer cells in a nude mouse xenograft model.

H. Chung, Yung-Hyun Choi, E. Im, 2017, International journal of oncology.

An analogue of resveratrol HS-1793 exhibits anticancer activity against MCF-7 cells via inhibition of mitochondrial biogenesis gene expression

Jin Han, Y. Yoo, B. Rhee, 2012, Molecules and cells.

Resveratrol analogue, HS-1793, induces apoptotic cell death and cell cycle arrest through downregulation of AKT in human colon cancer cells.

Min Jeong Kim, H. Chung, Jee H Jung, 2017, Oncology reports.

Anti-angiogenic activity of ursodeoxycholic acid and its derivatives.

T. Kim, H. Suh, H. Y. Lee, 1997, Cancer letters.

HS-1793, a resveratrol analogue, downregulates the expression of hypoxia-induced HIF-1 and VEGF and inhibits tumor growth of human breast cancer cells in a nude mouse xenograft model.

H. Chung, Yung-Hyun Choi, E. Im, 2017, International journal of oncology.